Hydralazine, used for well-controlled hypertension, is associated with drug-induced lupus or vasculitis, but negative ANA and p-ANCA ruled out its relevance, with PR3-ANCA confirming GPA [14]. The gene discussed is GYPA; the disease is systemic lupus erythematosus.